EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications

Nadia Saoudi González, Francesc Salvà, Javier Ros iD, Iosune Baraibar iD, Marta Rodríguez-Castells, Ariadna García, Adriana Alcaráz, Sharela Vega, Sergio Bueno iD, Josep Tabernero iD, Elena Elez

Cancers · 08.08.2023 · 15 (16) · 4020

DOI: 10.3390/cancers15164020 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 08.08.2023. Verfasst von Nadia Saoudi González und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a global health concern and a leading cause of death worldwide. The disease’s course and response to treatment are significantly influenced by its heterogeneity, both within a single lesion and between primary and metastatic sites. Biomarkers, such as mutations in KRAS, NRAS, and BRAF, provide valuable guidance for treatment decisions in patients with metastatic CRC. While high concordance exists between mutational status in primary and metastatic lesions, some heterogeneity may be present. Circulating tumor DNA (ctDNA) analysis has proven invaluable in identifying genetic heterogeneity and predicting prognosis in RAS-mutated metastatic CRC patients. Tumor heterogeneity can arise from genetic and non-genetic factors, affecting tumor development and response to therapy. To comprehend and address clonal evolution and intratumoral heterogeneity, comprehensive genomic studies employing techniques such as next-generation sequencing and computational analysis are essential. Liquid biopsy, notably through analysis of ctDNA, enables real-time clonal evolution and treatment response monitoring. However, challenges remain in standardizing procedures and accurately characterizing tumor subpopulations. Various models elucidate the origin of CRC heterogeneity, highlighting the intricate molecular pathways involved. This review focuses on intrapatient cancer heterogeneity and genetic clonal evolution in metastatic CRC, with an emphasis on clinical applications.

Schlagwörter

Stichwörter der Autor:innen

biomarkersclonal evolutionctDNAmetastatic colorectal cancertumor heterogeneity

Autor:innen und Institutionen

  • Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
  • Oncology Department, Vall d'Hebron Hospital, 08035 Barcelona, Spain.

ORCID-Profile: Javier Ros, Iosune Baraibar, Sergio Bueno, Josep Tabernero

Zitieren

APA

Saoudi González, N., Salvà, F., Ros, J., Baraibar, I., Rodríguez-Castells, M., García, A., Alcaráz, A., Vega, S., Bueno, S., Tabernero, J., & Elez, E. (2023). Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications. Cancers, 15(16), 4020. https://doi.org/10.3390/cancers15164020

Vancouver

Saoudi González N, Salvà F, Ros J, Baraibar I, Rodríguez-Castells M, García A, et al. Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications. Cancers. 2023;15(16):4020. doi:10.3390/cancers15164020

BibTeX
@article{SaoudiGonzlez2023,
  author = {Saoudi González, Nadia and Salvà, Francesc and Ros, Javier and Baraibar, Iosune and Rodríguez-Castells, Marta and García, Ariadna and Alcaráz, Adriana and Vega, Sharela and Bueno, Sergio and Tabernero, Josep and Elez, Elena},
  title = {Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {16},
  pages = {4020},
  doi = {10.3390/cancers15164020}
}
Kostenlos starten →